Drug Profile
Research programme: BLI 0901 - Biolite
Latest Information Update: 07 Sep 2020
Price :
$50
*
At a glance
- Originator BioLite Inc
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer(New delivery system) in Taiwan
- 30 Jan 2013 Preclinical trials in Breast cancer in Taiwan (unspecified route)